Trial Profile
Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2014
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Everolimus; Pravastatin; Zotarolimus
- Indications Acute coronary syndromes; Atherosclerosis; Coronary artery restenosis; Myocardial infarction; Unstable angina pectoris
- Focus Pharmacodynamics
- 04 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 28 May 2013 New trial record